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SUMMARY – A case is presented of a 67-year-old male patient with atypical non-small cell 
lung cancer, where inguinal lymph node metastases were the first sign of disease relapse. The patient 
had a long-term smoking history of 30 cigarettes per day, with no other important personal or family 
medical history data. Because of prolonged cough, the patient underwent diagnostic procedure, 
which revealed squamous cell carcinoma of the lung (stage IIIB, T3N2M0). Concomitant radio-
chemotherapy and consolidation chemotherapy according to PE protocol was administered. Multi-
slice computed tomography performed upon chemotherapy completion showed almost complete 
tumor regression and withdrawal of mediastinal lymph node enlargement, and the patient felt well. 
However, in the next few months, enlarged lymph nodes appeared in both inguinal regions. Histo-
pathologic analysis revealed metastatic lung cancer. Four months after the presentation of enlarged 
inguinal lymph nodes, lung cancer metastases were also diagnosed in the liver and lumbosacral 
spine. Despite additional treatments, the patient died four months later. Although it is well known 
that inguinal lymph nodes can harbor lung cancer metastases, in our patient inguinal lymph node 
metastases were the first sign of lung cancer relapse.
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Introduction
Lung cancer, the most common cause of cancer-
related death in men and women, is responsible for 1.3 
million deaths worldwide annually1. The most common 
symptoms are shortness of breath, coughing, hemopty-
sis and weight loss. Only 30% of these carcinomas are 
diagnosed in surgically treatable stage, usually present-
ing with long lasting cough and hemoptysis. The vast 
majority of primary lung cancers are carcinomas of the 
lung, derived from epithelial cells. The main types of 
lung cancer are small cell lung carcinoma (SCLC) and 
non-small cell lung carcinoma (NSCLC). This distinc-
tion is important because the treatment varies; NSCLC 
is sometimes treated with surgery, while SCLC usually 
responds better to chemotherapy and irradiation2. The 
most common cause of lung cancer is long-term expo-
sure to tobacco smoke. More often, NSCLC presents 
in advanced stage, where surgical treatment is not rec-
ommended and oncologic therapy is the treatment of 
choice. It is well known that NSCLC usually spreads 
into mediastinal lymph nodes, liver, brain and adrenals2. 
Metastasizing of NSCLC to other parts of the body is 
very rare, while metastases in inguinal lymph nodes, 
L. Grandić et al. Atypical non-small cell lung cancer presentation
442 Acta Clin Croat,  Vol. 49,   No. 4,  2010
at the same time being the first sign of disease relapse, 
present an exceptional situation. Lung cancer may be 
seen on chest radiograph and multi-slice computed 
tomography (MSCT). The diagnosis is confirmed by 
biopsy. It is usually performed by bronchoscopy or 
CT-guided biopsy. Our 67-year-old male patient is 
described as an atypical NSCLC presentation, where 
metastases to inguinal lymph nodes were the first sign 
of disease relapse.
Case Report
A 67-year-old man presented to his general prac-
titioner because of cough lasting for four months. 
The patient had a long lasting smoking history of 30 
cigarettes per day, with no other important personal 
or family medical history data. On physical examina-
tion, the patient appeared fatigued. No rash or lymph-
adenopathy was detected. Chest x-ray performed at 
the time revealed no pathologic finding. Since the pa-
tient’s health worsened and the symptoms progressed, 
two months later a new chest x-ray was performed to 
reveal inhomogeneous opacity in the right perihilar 
region. MSCT of the chest showed a tumor in the 
right lung lobe, measuring 5.5 cm in diameter (Fig. 
1). There was also an enlarged (13 mm) mediastinal 
lymph node, with a very small amount of cytologi-
cally verified malignant pleural effusion. Fiberoptic 
bronchoscopy showed stricture in the right lower 
main bronchus with a tumor in its distal part. Bron-
choscopic biopsy revealed the presence of abnormal 
histology (NSCLC, squamous cell carcinoma) (Fig. 
2). The patient’s performance status was 90% accord-
ing to Karnofsky score (capable of normal activity, few 
symptoms or signs of disease). With the diagnosis of a 
locally advanced NSCLC (stage IIIB, T3N2M0), the 
patient was treated with radiotherapy (6000 cGy in 30 
fractions) and 4 cycles of chemotherapy with 75mg/
m2 of cisplatin (Cisplatin Pliva, Pliva, Croatia). Upon 
completion of concomitant radio-chemotherapy, the 
patient was treated with additional consolidation che-
motherapy following the PE protocol. The PE chemo-
therapy protocol consisted of 60 mg/m2 of i.v. cisplatin 
(Cisplatin Pliva, Pliva, Croatia) on day 1 and 120 mg/
m2 of oral etoposide (Vepesid, Bristol-Myers Squibb, 
Australia) on days 1-3. This regimen was repeated ev-
ery 21 days for four cycles. Chest MSCT performed 
after chemotherapy showed almost complete tumor re-
Fig. 1. Multi-slice computed tomography of the chest showing 
tumor in the right lung.
Fig. 2. Lung biopsy: squamous cell carcinoma; (A) H&E, X100; (B) H&E, X200.
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gression (measuring 0.6 cm in diameter) and complete 
withdrawal of enlarged mediastinal lymph nodes. The 
patient felt very well, with no other symptoms or signs 
of the disease. In the next few months, enlarged semi-
mobile lymph nodes measuring 2x1 cm and 3x2 cm 
appeared in both inguinal regions. Because the ingui-
nal region is an unusual location for metastasis from 
lung carcinoma, the patient was not suspected to have 
developed metastatic disease. Tumor markers were all 
within the normal range. Surgical extirpation of the 
lesion was performed for differential diagnosis. Histo-
pathologic examination of the lymph node revealed a 
metastatic low-grade squamous lung carcinoma (Fig. 
3). On immunohistochemistry, tumor cells were posi-
tive for high weight keratin, cytokeratin 5 (CK5) and 
cytokeratin 7 (CK7). Cytokeratin 20 (CK20), CEA, 
LCA, HMB45, PSA, chromogranin and synapto-
physin were all negative. Therefore, thorough work-
up was performed including x-ray of the lumbosacral 
spine and pelvis, brain, chest and abdominal MSCT, 
analysis of different tumor markers (CEA, CA 19.9, 
CA 72.4 and PSA), cystoscopy and colonoscopy. This 
work-up revealed no other primary tumor, and lung 
cancer metastases were also found in the liver and 
lumbosacral spine. Despite additional treatments, the 
patient died four months later.
Discussion
Primary solid malignant tumors of inguinal region 
are very rare3,4. Just opposite to primary tumors, meta-
static tumors frequently involve either inguinal lymph 
nodes or spermatic duct, and they are most commonly 
of gastrointestinal or urologic origin3.
Metastases of lung cancer usually occur in the liv-
er, brain, bones, kidneys and adrenals, however, me-
tastases of lung cancer to the spleen, skin, lungs and 
spermatic duct are also described. Extrathoracic nodal 
metastasis is a rare clinical finding in patients with 
NSCLC5. Therefore, the first signs of malignant lung 
disease relapse usually are related to these organs. It 
is well known that inguinal lymph nodes can harbor 
lung cancer metastases, and we describe a case where 
inguinal lymph node metastases were also the first 
sign of lung cancer relapse. Rare cases of inguinal me-
tastases from tumors above the diaphragm have been 
reported, only three of them with inguinal metasta-
sis recognized antemortem. In these cases, primary 
tumors were malignant mesothelioma, salivary duct 
carcinoma and breast carcinoma5. Kocak et al. report 
a case of lung carcinoma metastatic to inguinal lymph 
node as the only evidence of progressive lung cancer5.
Blood-borne, lymph-borne and per continuitatem 
metastases are the types of lung cancer metastazing, 
especially in cases of T2 tumors2. Inguinal lymph 
nodes and spermatic duct metastases are the examples 
of blood-borne and lymph-borne lung cancer metas-
tases6,7. However, lymph-borne or blood-borne me-
tastases in inguinal region are parameters of advanced 
disease (stage IV) and poor prognosis. The five-year 
survival rate for stage IV lung cancer is only 5% re-
gardless of radiotherapy or chemotherapy received8,9. 
Fig. 3. Lymph node biopsy: metastatic lung cancer; (A) H&E, X100; (B) H&E, X400.
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Surgical treatment is not appropriate for advanced 
NSCLC, but it remains a cornerstone of radical treat-
ment for IIIA and lower stage NSCLC10. 
In conclusion, although extremely rare, metastatic 
disease to the inguinal region in patients with a his-
tory of lung cancer should be considered on differ-
ential diagnosis of any lesion in the groin. Thorough 
pulmonologic work-up is mandatory in such cases, al-
though metastatically enlarged inguinal lymph nodes 
are more commonly due to gastrointestinal or urologic 
malignancies.
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Sažetak
ATIPIČNA MANIFESTACIJA NEMIKROCELULARNOG KARCINOMA PLUĆA: METASTAZE U 
INGVINALNE LIMFNE ČVOROVE KAO PRVI ZNAK RECIDIVA BOLESTI 
L. Grandić, Z. Pogorelić, J. Banović, G. Forempoher, N. Ilić i Z. Perko
Prikazuje se slučaj 67-godišnjeg bolesnika s neuobičajenim razvojem kliničke slike  planocelularnog karcinoma pluća, 
kod kojeg su metastaze u preponskim limfnim čvorovima bile prvi znak recidiva bolesti. Dugogodišnji je pušač koji puši 
oko 30 cigareta na dan, a osobna i obiteljska anamneza su bez osobitosti. Zbog dugotrajnog kašlja učinjena mu je dijagno-
stička obrada koja je pokazala da se radi o planocelularnom karcinom pluća (stadij IIIB, T3N2MO). S obzirom na stadij 
proširenosti tumora ordinirano je provođenje konkomitantne radio-kemoterapije i konsolidacijske kemoterapije, prema 
protokolu PE. Iako je kontrolna kompjutorizirana tomografija pokazala gotovo potpunu regresiju tumora i iako se bole-
snik osjećao značajno bolje, nekoliko mjeseci nakon provedene konsolidacijske kemoterapije pojavili su se povećani limfni 
čvorovi u obje preponske regije, patohistološka analiza kojih je pokazala metastatski planocelularni karcinom pluća. Četiri 
mjeseca nakon pojave metastaza u preponskim limfnim čvorovima dijagnosticirane su metastaze u jetri i lumbosakralnoj 
kralježnici. Unatoč provedenoj terapiji bolesnik je preminuo. Iako je poznato da preponski limfni čvorovi mogu biti sijelo 
metastatskog karcinoma pluća, ovdje se opisuje slučaj gdje su povećani preponski limfni čvorovi bili prvi znak recidiva 
bolesti.
Ključne riječi: Plućne novotvorine – patologija; Karcinom, ne-malih plućnih stanica – sekundarni; Karcinom, ne-malih pluć-
nih stanica – komplikacije; Stadiji novotvorine; Limfatična metastaza; Napredovanje bolesti; Prikaz slučaja
